电致发光 HfO2/TiO2活性生物界面 破坏代谢性抗辐射性,为强化放射免疫疗法扫清障碍
Electrogenic HfO2/TiO2 Living Biointerface Dismantles Metabolic Radioresistance for Amplified Radio-Immunotherapy
Guo Mengen, Sun Pengcheng, Xu Wenjie, Hao Xinyan, Tang Tiantian, Liu Xinying, Liao Dehua, Zhao Jiangshan, Huang Hai, Li Muyan, Xu Linghao, Lin Jianing, Peng Yanjin, Zhang Xinfeng, Hu Xiongbin, Xiang
Journal:ACS Nano
IF:17.3
DOI:10.1021/acsnano.6c08241
PMID:
Published:2026-08-31
research field:肿瘤微环境免疫治疗细菌工程癌症治疗生物杂化材料纳米医学放射生物学
Abstract
Radiotherapy (RT) efficacy in aggressive solid tumors is hindered by lactate-driven metabolic radioresistance and an immunosuppressive microenvironment. Here, we engineer a living biointerface (SHT) via in situ biomineralization of HfO 2 /TiO 2 onto an electrogenic Shewanella oneidensis chassis to address this multifaceted challenge. This structural integration bridges the bacterial metabolism with interfacial radiocatalysis. The TiO 2 shell acts as an efficient electron acceptor to accelerate bacterial extracellular electron transfer, driving rapid intratumoral lactate depletion, while the high-Z HfO 2 core enhances the X-ray energy deposition. Under irradiation, this synergistic biointerface initiates an oxidative burst and irreversible DNA damage, dismantling the lactate-associated antioxidant defense. In radioresistant triple-negative breast cancer models, this localized physicochemical disruption translates into tumor suppression, accompanied by immunogenic cell death and cGAS-STING pathway activation, reprogramming the immunosuppressive niche. Furthermore, the SHT platform demonstrates systemic biocompatibility, alongside RT-gated self-limiting clearance. Collectively, this work establishes a bioelectrogenic material platform that integrates metabolic barrier dismantling, radiocatalytic sensitization, and immune remodeling for refractory cancer therapy.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


